$4.07
-0.025-0.61%
At close: Feb 13, 4:00 PM EST
$4.03
-0.04-0.98%
After Hours: Feb 13, 5:17 PM EST
Comments
Loading...
BriaCell Therapeutics Corp Earnings Estimates
BCTXNASDAQ
BriaCell Therapeutics Earnings Estimates, EPS & Revenue | NASDAQ:BCTX
BriaCell Therapeutics (BCTX) is scheduled to report Q2 earnings on March 11, 2026. Analysts estimate EPS of $-4.84 and quarterly revenue of $840.00K.
In the most recent quarter (Q1), BriaCell Therapeutics reported EPS of $-4.35, missing estimates of $-3.28 by 0.33%. Revenue came in at $0.00, missing the estimate of $2.10M by 1.00%.
BriaCell Therapeutics has missed EPS estimates in 2 consecutive quarters.
Over the last 4 quarters, BriaCell Therapeutics has averaged an EPS surprise of 0.48% and a revenue surprise of 1.00%.
Earnings Date
Mar 11
EPS Estimate
$-4.840
Quarterly Revenue Estimate
$840.00K
Annual Revenue
(as of Oct 31)
(as of Oct 31)
–
BriaCell Therapeutics Earnings History
Analyze the earnings history of BriaCell Therapeutics using advanced sorting and filters.
BriaCell Therapeutics (BCTX) Earnings Per Share
The chart below shows BriaCell Therapeutics's reported EPS compared to analyst estimates over recent quarters.
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q1 | 2025-12-11 | $-4.35 | $-3.28 | -32.6 % |
| Q4 | 2025-10-16 | $-4.81 | $-3.28 | -46.7 % |
| Q1 | 2024-12-16 | $-33.00 | $-45.00 | 26.7 % |
| Q4 | 2024-10-29 | $-10.50 | $-78.00 | 86.5 % |
BriaCell Therapeutics (BCTX) Revenue
The chart below shows BriaCell Therapeutics's reported revenue compared to analyst estimates over recent quarters.
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q1 | 2025-12-11 | $0 | $2.10M | -100.0 % |
| Q4 | 2025-10-16 | $0 | $2.10M | -100.0 % |
FAQ
When is BriaCell Therapeutics (NASDAQ:BCTX) reporting earnings?
BriaCell Therapeutics (BCTX) is scheduled to report earnings on March 11, 2026. The last reported earnings were for reported on December 11, 2025 for Q1.
What were the latest earnings per share (EPS) for BriaCell Therapeutics (NASDAQ:BCTX)?
The Actual EPS was $-4.35, which missed the estimate of $-3.28.
What were BriaCell Therapeutics’s (NASDAQ:BCTX) revenues?
The Actual Revenue was $0.00, which missed the estimate of $2.10M.
